Advertisement

Pertussis is Back and Now What?

  • Nicole Guiso
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 549)

Abstract

Vaccination is one of the most successful tools for controlling infectious diseases. Today millions of lives are saved because of vaccination against tetanus, diphtheria, whooping cough, poliomyelitis, meningitis, measles. Although it is generally perceived as the “golden solution,” it has been shown recently that the extensive use of vaccines may lead to undesirable effects (e.g., poliomyelitis epidemics due to vaccine-derived viruses) or the resurgence of a disease (e.g., reemergence of whooping cough after 40 years of vaccination). In the documented cases, epidemiological studies clearly indicate that extensive vaccination can induce modifications of pathogens over time, the emergence of new pathogens due to changes in ecosystems, or change in the transmission of the disease. Therefore, to optimize the benefits of immunization programs and prevent global adverse effects of vaccines (and the subsequent detrimental impact to the general public), the consequences of extensive vaccinations on the pathogen, ecosystem, and/or human host populations remain to be evaluated.

Keywords

Vaccine Strain Pertussis Toxin Pertussis Vaccine Bordetella Pertussis Whooping Cough 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Centers for Disease Control for Prevention. (2002). Pertussis-United States, 1997-2000. MMWR 51, 73–76.Google Scholar
  2. Baron, S., Njamkepo, E., Grimprel, E., Begue, P., Desenclos, J.C., Drucker, J., and Guiso, N. (1998). Epidemiology of pertussis in French hospitals in 1993 and 1994: Thirty years after a routine use of vaccination. Pediat. Inf. Dis. J. 17, 412–418.CrossRefGoogle Scholar
  3. Bordet, J. and Gengou, O. (1906). L’endotoxine coquelucheuse. Ann. Inst. Pasteur 415–419.Google Scholar
  4. Crowcroft, N.S., Andrews, N., Rooney, C., Brisson, M., and Miller, E. (2002). Deaths from pertussis are underestimated in England. Arch. Dis. Child. 86, 336–338.PubMedCrossRefGoogle Scholar
  5. De Melker, H.E., Schellekens, J.F.P., Neppelenbroek, S.E., Mooi, F.R., Rümke, H.C., and Conyn-van Spaendonck, M.A.E. (2000). Reemergence of pertussis in the highly vaccinated population of the Netherlands: Observations on surveillance data. Emerg. Infect. Dis. 6, 348–357.PubMedCrossRefGoogle Scholar
  6. Floret, D., Groupe de pathologie infectieuse pédiatrique, and Groupe francophone de réanimation et d’urgence pédiatrique. (2001). Les décès par infection bactérienne communautaire. Enquête dans les services de réanimation pédiatrique français. Arch. Pediatr. 8, 705–711.CrossRefGoogle Scholar
  7. Heininger, U., Stehr, K., and Cherry, J.D. (1992). Serious pertussis overlooked in infants. Eur. J. Pediatr. 151, 342–343.PubMedCrossRefGoogle Scholar
  8. Heininger, U., Stehr, K., Schmidt-Schlapfer, G., Penning, R., Vock, R., Kleemann, W., and Cherry, J.D. (1996). Bordetella pertussis infections and sudden unexpected deaths in children. Eur. J. Pediatr. 155, 551–553.PubMedCrossRefGoogle Scholar
  9. Juretzko, P., Fabian-Marx, T., Haastert, B., Giani, G., von Kries, R., von Wirsing, K. et al. (2001). Pertussis in Germany: Regional differences in management and vaccination status of hospitalized cases. Epidemiol. Infect. 127, 63–71.PubMedCrossRefGoogle Scholar
  10. Lindgren, C., Milerad, J., and Lagercrantz, H. (1997). Sudden infant death and prevalence of whooping cough in the Swedish and Norwegian communities. Eur. J. Pediatr. 156, 405–409.PubMedCrossRefGoogle Scholar
  11. Locht, C., Antoine, R., and Jacob-Dubuisson, F. (2001). Bordetella pertussis, molecular pathogenesis under multiple aspects. Curr. Opin. Microbiol. 4, 82–89.PubMedCrossRefGoogle Scholar
  12. Mooi, F.R., Van Oirschot, H., Heuvelman, K., Van der Heide, H.G.J., Gaastra, W., and Willems, R.J.L. (1998). Polymorphism in the Bordetella pertussis virulence factors P.69/pertactin and pertussis toxin in the Netherlands: Temporal trends and evidence for vaccine-driven evolution. Infect. Immun. 66, 670–675.PubMedGoogle Scholar
  13. Nicoll, A. and Gardner, A. (1988). Whooping cough and unrecognised postperinatal mortality. Arch. Dis. Child. 63, 41–47.PubMedCrossRefGoogle Scholar
  14. Njamkepo, E., Rimlinger, F., Thiberge, S., and Guiso, N. (2002). Thirty-five years’ experience with the whole-cell pertussis vaccine in France: Vaccine strains analysis and immunogenicity. Vaccine 20, 1290–1294.PubMedCrossRefGoogle Scholar
  15. Plotkin, S.A. and Cadoz, M. (1997). The acellular pertussis vaccine trials: An interpretation. Ped. Infect. Dis. J. 16, 508–517; discussion 517-519.CrossRefGoogle Scholar
  16. Van Loo, I.H.M., Van der Heide, H.G.J., Nagelkerke, N.J.D., Verhoef, J., and Mooi, F.R. (1999). Temporal trends in the population structure of Bordetella pertussis during 1949-1996 in a highly vaccinated population. J. Infect. Dis. 179, 915–923.PubMedCrossRefGoogle Scholar
  17. Weber, C., Boursaux-Eude, C., Coralie, G., Caro, V., and Guiso, N. (2001). Polymorphism of Bordetella pertussis isolates circulating the last ten years in France, where a single effective whole-cell vaccine has been used for more than thirty years. J. Clin. Microbiol. 39, 4396–4403.PubMedCrossRefGoogle Scholar
  18. Wirsing von König, C.H., Halperin, S., Riffelmann, M., and Guiso, N. (2002). Pertussis of adults and infants. Lancet Infect. Dis. 2, 744–750.CrossRefGoogle Scholar

Copyright information

© Science+Business Media New York 2004

Authors and Affiliations

  • Nicole Guiso

There are no affiliations available

Personalised recommendations